Abhishek Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.29 M
- Company Age 44 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 M
- Revenue Growth -52.00%
- Profit Growth -91.76%
- Ebitda -85.60%
- Net Worth 222.65%
- Total Assets 24.75%
About Abhishek Biotech
Abhishek Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 December 1980 and has a history of 44 years and one month. Its registered office is in Meerut, Uttar Pradesh, India.
The Corporate was formerly known as Kay Dee Pharma Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.29 M.
The company currently has active open charges totaling ₹6.00 M.
Abhishek Goel and Kunal Goel serve as directors at the Company.
Company Details
-
Location
Meerut, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100UP1980PTC005163
-
Company No.
005163
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Dec 1980
-
Date of AGM
29 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Abhishek Biotech?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Abhishek Goel | Director | 12-Mar-2005 | Current |
Kunal Goel | Director | 01-Nov-2011 | Current |
Financial Performance of Abhishek Biotech.
Abhishek Biotech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 52% decrease. The company also saw a substantial fall in profitability, with a 91.76% decrease in profit. The company's net worth Soared by an impressive increase of 222.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Abhishek Biotech?
Unlock access to Abhishek Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹6.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.60 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
15 Oct 2018 | State Bank Of India | ₹6.00 M | Open |
How Many Employees Work at Abhishek Biotech?
Unlock and access historical data on people associated with Abhishek Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abhishek Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abhishek Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.